Rohtak News Magazine

Thyroid Cancer Diagnostics Market Share Expected to Gain USD 3.84 Billion By 2028, at 5.7% CAGR Globally: Polaris Market Research

 Breaking News
  • No posts were found

Thyroid Cancer Diagnostics Market Share Expected to Gain USD 3.84 Billion By 2028, at 5.7% CAGR Globally: Polaris Market Research

February 24
09:04 2022
Thyroid Cancer Diagnostics Market Share Expected to Gain USD 3.84 Billion By 2028, at 5.7% CAGR Globally: Polaris Market Research
According to the latest research report, the demand of global Thyroid Cancer Diagnostics Market size & share was valued at approximately USD 2.50 Billion in 2020 in 2020 and is expected to reach a value of around USD 3.84 Billion By 2028, at a compound annual growth rate (CAGR) of about 5.7% during the forecast period 2021 to 2028.

According to the latest research report, the demand of global Thyroid Cancer Diagnostics Market size & share was valued at approximately USD 2.50 Billion in 2020 in 2020 and is expected to reach a value of around USD 3.84 Billion By 2028, at a compound annual growth rate (CAGR) of about 5.7% during the forecast period 2021 to 2028.

Thyroid cancer is a cancer of cells that attack the thyroid. Specific factors like a low iodine diet, exposure to radiation, and defective genes can increase the risks. The symptoms of thyroid cancer include growth and a lump in the neck, known as a thyroid nodule. The existence of nodules can be attributed to trouble swallowing and breathing, deprivation of voice, and swollen lymph nodes in the neck. Thyroid cancer can be diagnosed by a blood test that regulates levels of hormones and investigates if the thyroids can function correctly. Other diagnostic tests include biopsy, radioiodine scan, and imaging scans.

Thyroid cancer diagnostics depends on the size of the tumor and the spreading of cancer. Surgery is the most standard cure for thyroid cancer. Determined by the location and size of the cancer, the tumor may be removed by the surgeon. Also, the lymph nodes may be removed where the cancer cells have increased. Thyroid cancer can be prevented through preventive surgery, which includes genetic tests that decide if an altered gene is being carried, which expands the probability of medullary thyroid cancer. If the patient has a faulty gene, preventive surgery can be exercised to separate the thyroid gland before developing the thyroid.

Request Sample Copy of Research Report @ https://www.polarismarketresearch.com/industry-analysis/thyroid-cancer-diagnostics-market/request-for-sample

Key Highlights of The Report

  • Market intellect to authorize decision making that is effective
  • Trend analyses and growth opportunities
  • Revenue forecast segment and region-wise for assessment of the global thyroid cancer diagnostic market
  • Market share analysis and competition strategy
  • For staying ahead of the curve, listing of product innovation
  • Impact of covid-19 and the sustenance in these markets that are fast evolving

 

Important Questions Being Answered by The Market Report

  • What is the global thyroid cancer diagnostic market size and growth?
  • Which section is responsible for the largest thyroid cancer diagnostics market share?
  • Who are the significant players?
  • What are the factors driving the market?
  • Why is imaging used for the diagnosis of cancer?

 

Top Market Players Are:

  • Abbott
  • Roche Ltd
  • Thermo Fisher Scientific
  • Siemens Healthcare
  • Bio-Rad Laboratories
  • General Electric
  • Koninklijke Philips
  • Toshiba Corporation
  • Agilent Technologies
  • Illumina Inc

 

Request for Discount on this Report @ https://www.polarismarketresearch.com/industry-analysis/thyroid-cancer-diagnostics-market/request-for-discount-pricing

Thyroid Cancer Diagnostics Market: Growth Leading Factors

Discovering cancer with an imaging test assists healthcare professionals in determining the treatment course for the patient. The growing prevalence of cancer demand for imaging modalities is swiftly growing in the global thyroid cancer diagnostic market. To satiate the increasing need, techniques and technologies are commercialized by market players and boosting the prevalent competition. Additionally, technological developments extensively bring about the growth of the industry by enhancing its rates of acceptance.

Papillary carcinoma is the most ordinary kind of thyroid cancer and has the survival rate that is the highest. The cure for papillary carcinoma includes thyroid hormone therapy, surgery, radioactive iodine, and chemotherapy. In the past two decades, the issue has risen remarkably. This increase can be due to excessive intake of sugary and fatty food items, environmental issues, and lifestyles that are sedentary. Therefore, the papillary carcinoma market has seen a sharp rise due to these factors.

The flare-up of covid-19 influenced the global thyroid cancer diagnostics market. There was a significant reduction in hospital visits, and usage of health care services remarkably lessened because of the measures that are social distancing thrust by governments globally. For check-ups, patients are unable to visit the hospitals. Thus covid-19 has displayed a decline in the market.

Directly Purchase a copy of the report with TOC @ https://www.polarismarketresearch.com/checkouts/7761

Thyroid Cancer Diagnostics Market: Report Scope

Report Attribute

Details

Market Size 2020 Value

USD 2.50 Billion

Market Outlook for 2028

USD 3.84 Billion

Expected CAGR Growth

5.7% from 2021 – 2028

Base year

2020

Forecast period

2021 – 2028

Segments covered

By Type, By Technique, By End-Use, By Region

Key Companies

Abbott, Roche Ltd, Thermo Fisher Scientific, Siemens Healthcare, Bio-Rad Laboratories, General Electric, Koninklijke Philips, Toshiba Corporation, Agilent Technologies, and Illumina, Inc

Regional scope

North America, Europe, Asia Pacific, Latin America, Middle East & Africa

Customization Options

Customized purchase options are available to meet your research needs.

 

Thyroid Cancer Diagnostics Market: Key Segmentation

  • Insight by type, technique, end-use, and region

 

By type, papillary carcinoma ruled the roost due to its having the highest cure rates compared to other cancers, with a survival rate of five years. By technique, imaging tests dominate the market. CT/MRI scan and neck ultrasound are the most endorsed diagnostic tools for disease identification. Technological developments with high costs are important revenue generators for this segment in the global thyroid cancer diagnostics market. By end-use, hospital laboratories have the largest market share owing to growing patient inflow for diagnosis of cancer in hospitals, increasing consumer awareness, and increasing investment in the infrastructure of hospitals in underdeveloped and developed countries.

By region, North America is the leading region for this global thyroid cancer diagnostic market as it has given robust commercial performances in the US. The growth can be attributed to government initiatives that are favorable, growth in healthcare expenditure, and the prevalence of significant manufacturers. The other region for the market in the Asia Pacific is because of factors like the growing prevalence of thyroid cancer, an increase in consumer awareness development in infrastructure of healthcare, and growth in disposable income.

Browse the full “Thyroid Cancer Diagnostics Market Share, Size, Trends, Industry Analysis Report, By Type (Papillary Carcinoma, Follicular Carcinoma); By Technique (Blood Test, Imaging, Biopsy); By End-Use (Hospital Laboratories, Cancer Diagnostics Centers, Research Institutes); By Regions; Segment Forecast, 2021 – 2028” Report at https://www.polarismarketresearch.com/industry-analysis/thyroid-cancer-diagnostics-market

The market primarily depends on the type, technique, end-use, and region

Thyroid Cancer Diagnostics Market: By Type

  • Papillary Carcinoma
  • Follicular Carcinoma
  • Others

 

Thyroid Cancer Diagnostics Market: By Technique

  • Blood Test
  • Imaging
  • Biopsy
  • Others

 

Thyroid Cancer Diagnostics Market: End-Use

  • Hospital Laboratories
  • Cancer Diagnostics Centers
  • Research Institutes
  • Others

 

About Us:

Polaris Market Research is a worldwide market research and consulting organization. We give unmatched nature of offering to our customers present all around the globe across industry verticals. Polaris Market Research has expertise in giving deep-dive market insight along with market intelligence to our customers spread crosswise over various undertakings. We at Polaris are obliged to serve our different client base present over the enterprises of medicinal services, healthcare, innovation, next-gen technologies, semiconductors, chemicals, automotive, and aerospace & defense, among different ventures, present globally.

Media Contact
Company Name: Polaris Market Research and Consulting
Contact Person: Likhil
Email: Send Email
Phone: +1-9292-97-97-27
Address:30 Wall Street 8th Floor, New York City, NY 10005, United States
City: New York City
State: US
Country: United States
Website: https://www.polarismarketresearch.com/industry-analysis/thyroid-cancer-diagnostics-market

Related Articles

Recent Posts

StarCard Sports Games soccer NFT collection sells out again in minutes on the ARC NFT Marketplace

Read Full Article